Hims & Hers Health, Inc. Class A HIMS 深 沪
等待开盘 03-27 09:30:00 美东时间
20.88
+0.020
+0.10%
华盛通- 最 高27.54
- 今 开20.57
- 成交量 1877.92万股
- 最 低 15.21
- 昨 收 20.86
- 总市值 430.13万
- 52周最高 70.43
- 市盈率 静 --
- 换手率 9116.13%
- 52周最低 13.74
- 委 比 71.14%
- 总股本 0.00亿
- 历史最高 72.98
- 量 比 0.87
- 振 幅 59.11%
- 历史最低 2.72
- 每 手 1
- 风险率 13.37%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多What's Happening With Novo Nordisk Stock Today?
Novo Nordisk A/S (NYSE:NVO) shares are moving higher on Thursday. Hims & Hers Health Inc (NYSE:HIMS) announced it will begin offering several of the Novo's FDA‑approved GLP‑1 medications, including the newly launched Wegovy pill.
今天 01:47
India's Generic Wave Hits Ozempic And Wegovy As Prices Drop Sharply
India's drugmakers roll out low-cost copies for Novo Nordisk's semaglutide, slashing prices up to 70% as analysts weigh global market disruption risks.
03-23 21:00
Lucid Tops The Most-Shorted Stock List—Here Are 9 More Short Targets
Lucid, CleanSpark and Hims & Hers are the top 3 most shorted stocks. Here's the rest of the top ten.
03-12 03:20
Europe In Review: Natural Gas Prices Spike As Europe Splits Over US‑Israeli Strikes
European natural gas prices climbed to a three-year high on Tuesday due to US‑I...
03-10 22:47
Crude Oil Rises Around 4%; Xenon Pharmaceuticals Shares Surge
US stocks fell, Nasdaq down 1%, Dow down 1.71%, S&P 500 down 1.43%. Energy shares down 0.1%, consumer discretionary stocks down 2.8%. ZIM stock up after Q4 results. Autozi shares up 143%, Xenon Pharma up 41%, Hims & Hers up 38%. Silynxcom down 22%, Venu down 19%, Zeta down 16%.
03-10 02:50
Market-Moving News for March 9th
HIMS: 54% | Novo Nordisk And Hims & Hers End Bitter Legal Feud With Surprise Weight-Loss Drug Deal: Report RLMD: 80% | Relmada Therapeutics Announces 12-month Interim Data From Its
03-09 19:30
Hims & Hers, Novo Nordisk Weight-Loss Drug Deal Ends Legal Feud, Stock Soars
Hims & Hers stock jumps 49% premarket after ending lawsuit with Novo Nordisk and securing weight-loss drug partnership.
03-09 19:04
BTIG Downgrades Hims & Hers Health to Neutral
BTIG analyst David Larsen downgrades Hims & Hers Health (NYSE:HIMS) from Buy to Neutral.
02-25 02:04
Hims & Hers Health: Q4 Earnings Insights
Hims & Hers Health (NYSE:HIMS) just disclosed its Q4 earnings on Monday, Fe...
02-24 05:08
Nvidia, Joby, CoreWeave, Lucid and More Stocks with Earnings This Week
Here's a look at the earnings calendar for the week ahead, including reports from Nvidia, Joby, CoreWeave, Salesforce, Lucid and more.
02-23 23:33
